DHE |
ISIN | DE000A2E4K43 |
Security | DHE |
Exchange | EUREX |
Type | Option |
Options
Exp. date | Type | Type |
---|---|---|
3/21 | 42 Calls | 41 Puts |
4/21 | 14 Calls | 14 Puts |
5/21 | 10 Calls | 10 Puts |
6/21 | 31 Calls | 30 Puts |
9/21 | 16 Calls | 16 Puts |
12/21 | 31 Calls | 31 Puts |
6/22 | 19 Calls | 19 Puts |
12/22 | 22 Calls | 22 Puts |
6/23 | 11 Calls | 11 Puts |
12/23 | 23 Calls | 23 Puts |
12/24 | 15 Calls | 15 Puts |
12/25 | 8 Calls | 8 Puts |
Calls
Strike | Last | Open Interest | |
---|---|---|---|
44.00 | 66.60 | 10 | |
48.00 | 60.80 | 10 | |
52.00 | 63.95 | 20 | |
100.00 | 36.10 | 2,221 | |
110.00 | 35.45 | 2 | |
120.00 | 16.55 | 14,881 | |
130.00 | 22.90 | 6 | |
140.00 | 16.00 | 6,528 | |
150.00 | 9.50 | 5 | |
160.00 | 6.90 | 14,591 | |
170.00 | 6.60 | 1,200 | |
180.00 | 7.25 | 6,404 | |
200.00 | 2.35 | 124 |
News
- Delivery Hero jumps 8% on S. Korea deal approval
12/28/2020 / 11:45 - TeleTrader - Satsuma Pharmaceuticals to Participate in the Evercore ISI 3rd Annual HealthCONx Conference
11/24/2020 / 22:16 - GlobeNewswire - Satsuma Pharmaceuticals Provides Business Update and Reports Third Quarter 2020 Financial Results
11/10/2020 / 22:02 - GlobeNewswire - Satsuma Pharmaceuticals to to participate in the following November Virtual Investor Conferences
11/02/2020 / 22:34 - GlobeNewswire - Satsuma Pharmaceuticals Announces Topline Results from EMERGE Phase 3 Trial of STS101 for the Acute Treatment of Migraine
09/10/2020 / 14:00 - GlobeNewswire